Published in Br Heart J on July 01, 1977
Haemodynamic effects of nifedipine in heart failure. Br Heart J (1980) 2.32
Salbutamol in treatment of heart failure. Br Heart J (1980) 1.27
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin. Br Med J (Clin Res Ed) (1985) 1.12
Bedside haemodynamic monitoring: experience in a general hospital. Br Med J (Clin Res Ed) (1983) 0.99
Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses. Br Med J (Clin Res Ed) (1981) 0.94
Effects of sodium nitroprusside upon cardiac work, efficiency, and substrate extraction in severe left ventricular failure. Br Heart J (1981) 0.84
Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure. Br Heart J (1982) 0.84
Salbutamol in cardiogenic shock complicating acute myocardial infarction. Br Heart J (1980) 0.82
Cardiogenic shock. Postgrad Med J (1985) 0.80
Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate. Br Heart J (1983) 0.79
Modern treatment of heart failure. BMJ (1988) 0.77
A comparison of the effects of hydrallazine, diazoxide, sodium nitrite and sodium nitroprusside on human isolated arteries and veins. Br J Clin Pharmacol (1981) 0.76
Circulatory effects of controlled arterial hypotension with trimetaphan (Arfonad). Experimental study in patients with left ventricular failure. Br Heart J (1978) 0.75
Hydrallazine alone in acute left ventricular failure. Postgrad Med J (1981) 0.75
Beneficial effects of captopril in left ventricular failure in patients with myocardial infarction. Br J Clin Pharmacol (1982) 0.75
Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol (1967) 6.74
Force-velocity relations in mammalian heart muscle. Am J Physiol (1962) 3.68
Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work. Circulation (1959) 3.27
Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet (1972) 2.24
EFFECT OF CORONARY VASODILATOR DRUGS ON RETROGRADE FLOW IN AREAS OF CHRONIC MYOCARDIAL ISCHEMIA. Circ Res (1964) 2.14
Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation (1973) 2.08
Protection of jeopardized ischemic myocardium by reduction of ventricular afterload. N Engl J Med (1974) 1.92
Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med (1974) 1.78
Action of nitroglycerin on the coronary circulation in normal and in mild cardiac subjects. Circulation (1959) 1.77
Phentolamine for vasodilator treatment of severe heart-failure. Lancet (1971) 1.71
The role of vasodilator therapy in heart failure. Prog Cardiovasc Dis (1977) 1.69
Heart failure complicating acute myocardial infarction. Circulation (1972) 1.64
Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Am Heart J (1975) 1.58
Phentolamine and cardiovascular performance. Br Heart J (1969) 1.57
Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation (1973) 1.57
Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium. Am J Cardiol (1966) 1.50
Arterial impedance as ventricular afterload. Circ Res (1975) 1.43
Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis. Circulation (1976) 1.37
Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation (1973) 1.36
Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance. Circulation (1975) 1.36
Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction. Circulation (1972) 1.35
Intravenous nitroglycerin in acute myocardial infarction. Circulation (1975) 1.32
Oral hydralazine therapy for chronic refractory heart failure. Circulation (1976) 1.30
Hemodynamic effects of quantitatively varied experimental mitral regurgitation. Circ Res (1957) 1.24
Regional myocardial blood flow in the dog studied with radioactive microspheres. Cardiovasc Res (1971) 1.23
Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction. Am J Cardiol (1976) 1.18
Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation (1974) 1.17
Systemic and coronary hemodynamic effects of sodium nitroprusside. Am Heart J (1974) 1.16
Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure. Circulation (1975) 1.14
Hemodynamic effects of nitroglycerin in acute myocardial infarction. Circulation (1975) 1.12
Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin. Circulation (1975) 1.11
Failure of intracoronary nitroglycerin to alleviate pacing-induced angina. Circulation (1972) 1.09
Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction. N Engl J Med (1975) 1.06
Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation (1976) 1.03
Effect of nitroprusside on left ventricular dynamics in mitral regurgitation. Circulation (1974) 1.02
Reversal by phenylephrine of the beneficial effects of intravenous nitroglycerin in patients with acute myocardial infarction. N Engl J Med (1975) 1.01
Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction. Circulation (1972) 1.00
Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;. Circulation (1975) 0.96
Power failure in acute myocardial infarction. Prog Cardiovasc Dis (1970) 0.96
Left ventricular dysfunction following acute myocardial infarction. A clinicopathologic and hemodynamic profile of shock and failure. Am J Med (1973) 0.95
Use of phentolamine in acute myocardial infarction. Am Heart J (1974) 0.92
Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure. Ann Intern Med (1974) 0.91
Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. Haemodynamic study. Br Heart J (1975) 0.85
Phentolamine and beta-adrenergic receptors. J Clin Pharmacol New Drugs (1972) 0.85
Response of the left ventricle to nitroglycerin in patients with and without mitral regurgitation. Br Heart J (1974) 0.84
Editorial: Vasodilator therapy for heart failure. Ann Intern Med (1975) 0.84
Enhanced left ventricular performance with phentolamine in acute myocardial infarction. Am J Cardiol (1974) 0.83
Objective haemodynamic assessment after acute myocardial infarction. Br Heart J (1973) 0.83
Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin. Ann Intern Med (1975) 0.83
Effect of intra-aortic balloon counterpulsation on the motion and perfusion of acutely ischemic myocardium. An experimental echocardiographic study. Circulation (1976) 0.82
Vasodilator therapy in acute myocardial infarction. Mod Concepts Cardiovasc Dis (1974) 0.82
Acute myocardial infarction. V: Left and right ventricular haemodynamics in cardiogenic shock. Br Heart J (1974) 0.82
Effects of phentolamine on coronary blood flow in patients with recent myocardial infarction. Br Heart J (1975) 0.80
Studies of the central and peripheral hemodynamic effects of amyl nitrite in patients with aortic insufficiency. Circulation (1970) 0.78
The local effect of glyceryl trinitrate, nitrite, papaverine, and atropine upon coronary vascular resistance. Am Heart J (1962) 0.77
Effect of alterations of arterial blood pressure and heart rate on segmental dyskinesis during acute myocardial ischemia and following coronary reperfusion. Circ Res (1975) 0.77
Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation (1991) 7.94
Passive smoking and heart disease. Mechanisms and risk. JAMA (1995) 3.23
Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med (1973) 2.79
Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circ Res (1968) 2.69
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev (1999) 2.57
Assessment of passive elastic stiffness for isolated heart muscle and the intact heart. Circ Res (1973) 2.42
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med (1993) 2.39
Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res (2003) 2.12
Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation (1973) 2.08
Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation (1979) 2.08
Pharmacy madness. J Am Coll Cardiol (2000) 2.03
Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Circulation (1980) 2.02
Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem (2003) 1.97
Electrocardiographic changes subsequent to artificial ventricular depolarization. Br Heart J (1969) 1.88
Heart-block following acute myocardial infarction. Treatment with demand and fixed-rate pacemakers. Lancet (1968) 1.77
Comparison of transesophageal echocardiographic and scintigraphic estimates of left ventricular end-diastolic volume index and ejection fraction in patients following coronary artery bypass grafting. Anesthesiology (1990) 1.75
Diastolic pressure-volume relationship in the canine left ventricle. Circ Res (1971) 1.74
Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol (2000) 1.73
Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med (1989) 1.70
The role of vasodilator therapy in heart failure. Prog Cardiovasc Dis (1977) 1.69
Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol (1993) 1.68
Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol (1994) 1.66
Even a little secondhand smoke is dangerous. JAMA (2001) 1.65
Heart failure therapy in evolution. Circulation (1996) 1.64
Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med (1980) 1.63
Effects of isometric exercise on cardiac performance. The grip test. Circulation (1971) 1.63
The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J (1979) 1.63
Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation (1991) 1.61
Relation between mechanics of contraction and relaxation in mammalian cardiac muscle. Am J Physiol (1969) 1.60
Thallium-20 1 myocardial perfusion scintigraphy for the clinical clarification of normal, abnormal and equivocal electrocardiographic stress tests. Am J Cardiol (1978) 1.60
Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Am Heart J (1975) 1.58
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Cardiovascular effects of glucagon in man. N Engl J Med (1968) 1.56
Detection and characterization of acute myocardial infarction in man with use of gated magnetic resonance. Circulation (1985) 1.55
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Circulation (1982) 1.54
Series elasticity in heart muscle. Its relation to contractile element velocity and proposed muscle models. Circ Res (1967) 1.52
The risk of pacing after infarction, and current recommendations. Lancet (1969) 1.50
Effects of hypoxia on mechanics of cardiac contraction. Am J Physiol (1970) 1.47
Position report on cardiac rehabilitation. Recommendations of the American College of Cardiology. J Am Coll Cardiol (1986) 1.45
Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med (1976) 1.45
Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang (1997) 1.44
Length-dependent changes in myocardial contractile state. Am J Physiol (1973) 1.43
Testosterone relaxes rabbit coronary arteries and aorta. Circulation (1995) 1.42
Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J (1990) 1.40
The noninvasive diagnosis of right ventricular infarction. Circulation (1978) 1.39
The editorial process. J Am Coll Cardiol (1993) 1.39
Full disclosure: the antidote to conflict of interest. J Am Coll Cardiol (2000) 1.39
Depression of myocardial contractility in rats by free fatty acids during hypoxia. Circ Res (1970) 1.38
Clinical practice guidelines. Does the cookbook have enough recipes? JAMA (1994) 1.38
Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis. Circulation (1976) 1.37
Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence summary. J Am Coll Cardiol (1996) 1.37
Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation (1973) 1.36
Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation (1981) 1.35
Factors which affect the diastolic pressure-volume curve. Circ Res (1978) 1.35
Optimal level of filling pressure in the left side of the heart in acute myocardial infarction. N Engl J Med (1973) 1.32
The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development. Circ Res (1979) 1.31
Oral hydralazine therapy for chronic refractory heart failure. Circulation (1976) 1.30
Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. J Am Coll Cardiol (1999) 1.30
Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation (1996) 1.30
Myocardial mechanics in ppillary muscles of the rat and cat. Am J Physiol (1969) 1.30
Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). N Engl J Med (1976) 1.28
Depression of left ventricular function due to acute myocardial ischemia and its reversal after aortocoronary saphenous-vein bypass. N Engl J Med (1972) 1.27
The cavity electrocardiogram in emergency artificial pacing. Postgrad Med J (1969) 1.27
Emergency bypass surgery in impending and complicated acute myocardial infarction. Arch Surg (1972) 1.27
Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation (1973) 1.26
Fall of endocardial potentials after acute myocardial infarction. Lancet (1970) 1.26
Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine. J Pharmacol Exp Ther (1967) 1.22
In-vitro studies of myocardial asynchrony and regional hypoxia. Circ Res (1969) 1.22
Myocarditis and cardiomyopathy. Am Heart J (1984) 1.22
In vitro length-tension relations of human ventricular aneurysms. Relation of stiffness to mechanical disadvantage. Am J Cardiol (1973) 1.21
Noninvasive quantitation of myocardial infarction with technetium 99m pyrophosphate. Circulation (1975) 1.19
Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure. J Am Coll Cardiol (1983) 1.18
Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol (1977) 1.16
Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations. J Am Coll Cardiol (1983) 1.14
Pericardial effusion associated with minoxidil therapy. Arch Intern Med (1981) 1.14
Ventricular endocardial potentials after experimental coronary artery occlusion in dogs. Am Heart J (1971) 1.13
Passive and active smoking. A problem for adults. Circulation (1996) 1.12
Low intracardiac potentials in myocardial infarction as a cause of failure of inhibition of demand pacemakers. Lancet (1968) 1.11
Projected cost-effectiveness of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol (1997) 1.10
An analysis of segmental ischemic dysfunction utilizing the pressure-length loop. Circulation (1974) 1.10
Assessment of left ventricular function by single plane cineangiographic volume analysis. Br Heart J (1971) 1.10
Coronary sinus reflux. A source of error in the measurement of thermodilution coronary sinus flow. Circulation (1978) 1.10
Hemodynamic spectrum of myocardial infarction and cardiogenic shock. A conceptual model. Circulation (1972) 1.09